Thank you, if 20% success is encouraging to you Go for it. Yep it was so encouraging they blazed ahead in finishing recruitment. Let's see, when was this written:
"The company disclosed that 25 patients are now enrolled in their melanoma study and will shortly finish enrollment in their 15 patient Merkel Cell Carcinoma (MCC) study study, both of which are Phase II trials."